TABLE 4.
Results of robust mixed linear regression model for predictors of SLEDAI-2K. Individual Patient ID was included as random effect in the model. Predictor values were measured at all timepoints.
| Dependent: SLEDAI-2K | ||||
|---|---|---|---|---|
| Predictors | Estimate | Std. error | t. value | p |
| (Intercept) | 11.4386 | 1.1960 | 9.5644 | <0.001 |
| Month 6 | −2.9902 | 0.5108 | −5.8544 | <0.001 |
| Month 12 | −3.3201 | 0.5197 | −6.3886 | <0.001 |
| C3 | −0.0574 | 0.0140 | −4.1083 | 0.0004 |
| sTACI | −0.0002 | 0.0001 | −2.3424 | 0.0285 |
MODEL FIT: AIC = 300.13, BIC = 315.02 Pseudo-R2 (fixed effects) = 0.47 Pseudo-R2 (total) = 0.63. In bold p ≤ 0.050. SLEDAI-2K score, systemic lupus erythematosus disease activity index 2,000; sTACI: soluble transmembrane activator and calcium-modulator and cyclophilin ligand interactor; C3: complement factor 3.